Cargando…

Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study

BACKGROUND: Since its launch as a standardized treatment for multidrug-resistant tuberculosis (MDR-TB) in Ethiopia in April 2018, the safety profile of the shorter injectable regimen under a programmatic setting has not been well studied. Thus, this study aimed to assess the status of adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Achalu, Daniel Legese, Mohammed, Foziya Getachew, Teferi, Mekonnen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644888/ https://www.ncbi.nlm.nih.gov/pubmed/38023629 http://dx.doi.org/10.2147/TCRM.S423163

Ejemplares similares

Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2020)

Injectables’ key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes
por: Decroo, Tom, et al.
Publicado: (2020)

Drug-resistant tuberculosis: Progress towards shorter and safer regimens
por: Saravu, Kavitha, et al.
Publicado: (2019)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Magnitude of road traffic accident related injuries and fatalities in Ethiopia
por: Abegaz, Teferi, et al.
Publicado: (2019)

Programmatic Challenges in Managing Multidrug-Resistant Tuberculosis in Malawi
por: Charlie, Loveness, et al.
Publicado: (2021)

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope
por: Prasad, Rajendra, et al.
Publicado: (2017)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

Making the Case for All-Oral, Shorter Regimens for Children with Drug-Resistant Tuberculosis
por: Patankar, Sayalee, et al.
Publicado: (2023)

Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
por: Fofana, Mariam O., et al.
Publicado: (2014)

Inventory Management of Health Commodities in a Tertiary Teaching Hospital in Ethiopia
por: Legese, Nanati, et al.
Publicado: (2022)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Moxifloxacin concentration correlate with QTc interval in rifampicin-resistant tuberculosis patients on shorter treatment regimens
por: Kusmiati, Tutik, et al.
Publicado: (2022)

Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022)

The role of nutrition‐sensitive agriculture combined with behavioral interventions in childhood growth in Ethiopia: An adequacy evaluation study
por: Mekonnen, Tefera Chane, et al.
Publicado: (2022)

Shorter TB treatment regimens should be safer as well
por: Rucsineanu, O., et al.
Publicado: (2023)

Diabetes mellitus and tuberculosis: programmatic management issues
por: Harries, A. D., et al.
Publicado: (2015)

Magnitude and causes of first-line antiretroviral therapy regimen changes among HIV patients in Ethiopia: a systematic review and meta-analysis
por: Ataro, Zerihun, et al.
Publicado: (2019)

Magnitude of Spousal Violence and Associated Factors among Midlife Women in Ethiopia
por: Mekonnen, Birye Dessalegn, et al.
Publicado: (2023)

Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens
por: Park, Hae-Young, et al.
Publicado: (2023)

A shorter post-exposure prophylaxis regimen for rabies, Pakistan
por: Salahuddin, Naseem, et al.
Publicado: (2021)

Initial resistance to companion drugs should not be considered an exclusion criterion for the shorter multidrug-resistant tuberculosis treatment regimen
por: Lempens, Pauline, et al.
Publicado: (2020)

Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis
por: Trubnikov, Aleksandr, et al.
Publicado: (2021)

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan
por: Kohler, Stefan, et al.
Publicado: (2022)

Effectiveness and safety of fully oral modified shorter treatment regimen for multidrug-resistant tuberculosis in Georgia, 2019–2020
por: Avaliani, Teona, et al.
Publicado: (2021)

Guidelines for the programmatic management of drug-resistant tuberculosis emergency update 2008.
Publicado: (2008)

Magnitude and associated factors of Atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia
por: Kelbore, Abraham Getachew, et al.
Publicado: (2015)

Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
por: Wahid, Abdul, et al.
Publicado: (2022)

Oesophageal cancer magnitude and presentation in Ethiopia 2012–2017
por: Wondimagegnehu, Abigiya, et al.
Publicado: (2020)

Ethics, human rights and programmatic management of drug-resistant tuberculosis
por: Dholakia, Yatin N.
Publicado: (2012)

Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda
por: Mitnick, Carole D., et al.
Publicado: (2016)

Children as sentinels of tuberculosis transmission: disease mapping of programmatic data
por: Gunasekera, Kenneth S., et al.
Publicado: (2020)

Policy and practice of programmatic management of latent tuberculosis infection in The Netherlands
por: de Vries, Gerard, et al.
Publicado: (2017)

Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan
por: Gadoev, Jamshid, et al.
Publicado: (2021)

Factors associated with treatment outcome of MDR/RR-TB patients treated with shorter injectable based regimen in West Java Indonesia
por: Soeroto, Arto Yuwono, et al.
Publicado: (2022)

Pattern of and reasons for antiretroviral therapy regimen change among adult HIV/AIDS patients at regional hospital in Eastern Ethiopia: A 10-year retrospective study
por: Sisay, Mekonnen, et al.
Publicado: (2019)

Treatment Outcome and Adverse Events of Tenofovir Disoproxil Fumarate Based Regimens as Compared to Zidovudine Based Regimens Among People Living with HIV/AIDS: A Systematic Review and Meta-Analysis of Observational Studies
por: Kefale, Adane Teshome, et al.
Publicado: (2018)

Optimizing tuberculosis treatment efficacy: Comparing the standard regimen with Moxifloxacin-containing regimens
por: Budak, Maral, et al.
Publicado: (2023)

The Magnitude of Medication Administration Errors among Nurses in Ethiopia: a Systematic Review and Meta-analysis
por: Bifftu, Berhanu Boru, et al.
Publicado: (2020)

Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
por: Rosu, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u2bjc40i0noddtrbl8rl248qmm